RMR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
RMR is not a good buy right now. The setup is technically oversold near support, but momentum remains bearish (MACD worsening) and the latest quarter showed clear YoY deterioration in revenue, EPS, and net income. With no Intellectia buy signals today and limited options activity, the risk/reward does not justify an impatient entry at $15.05.
Price/Trend: The stock is sitting below the pivot (15.79) and near key supports (S1 15.238, S2 14.897), which suggests it’s in a weak/pressure zone rather than reclaiming an uptrend. Momentum: MACD histogram is -0.151 and negatively expanding, indicating bearish momentum is strengthening. Mean-reversion/Oversold: RSI_6 at 27.45 is oversold, which can support a short-term bounce attempt, but oversold alone is not a reliable buy trigger when MACD continues to deteriorate. Levels to watch: Immediate support is 14.90–15.24; a clean break below increases downside risk. Upside recovery would first need to reclaim ~15.79 (pivot) and then 16.34 (R1).
Intellectia Proprietary Trading Signals
near support can fuel a short-term rebound.
Pattern-based projection (similar candlesticks): points to potential +2.97% over the next week and +8.77% over the next month.
could be beatable.
Momentum trend is still bearish: MACD is negative and worsening, which often overrides oversold signals.
Fundamental deterioration in latest quarter increases downside risk if earnings disappoint.
No supportive news flow in the last week and no notable hedge fund/insider trend signals (both neutral).
Options market is not actively participating today (0 volume), limiting confidence in bullish positioning.
Latest quarter: 2025/Q4. Growth trends (YoY): Revenue $49.51M (-3.69%), Net Income $3.324M (-36.66%), EPS $0.20 (-37.50%). Gross margin 89.89% (-5.91%). Assessment: The quarter reflects weakening profitability and earnings power versus last year, which is a headwind for sustained upside unless the next report shows a clear re-acceleration.
Recent trend: A new initiation (2026-01-07) from Ladenburg with a Buy rating and a $17 price target; no other recent rating/target changes were provided. Wall Street pros: New Buy coverage and target above current price suggests perceived undervaluation or improvement potential. Wall Street cons: Limited analyst coverage data here and the most recent reported financials show declining revenue and sharply lower earnings, which can cap multiple expansion. Politicians/influential trading: No recent congress trading data available in the last 90 days.
